semaglutide gastroparesis class action in louisiana ileus legal team law office Incapacity Planning in Louisiana semaglutide law office in – louisiana semaglutide ileus attorney gastroparesis

Important safety information includes a boxed warning for thyroid C-cell tumors (contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) and warnings for pancreatitis, gallbladder disease, acute kidney injury, and hypoglycemia risk when used with insulin or sulfonylureas

PMID: 17 HeineRJGaalLFVJohnDMihmMJWidelMHBrodowsRGet al

Stage II Extended Trial (NCT06732245) Design: Evaluate the efficacy and safety of NA-931 peptide monotherapy or in combnation with Tirzepatide

Additionally, it has been associated with improvements in various metabolic factors, including blood sugar levels and blood pressure